ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Everyone's talking about empagliflozin"
Episode Synopsis
Maria Veiga-da-Cunha, Claudia Soler-Alfonso and Sarah Grünert join the podcast to talk about Empagliflozin, a repurposed drug with impressive efficacy in GSD 1b and G6PC3 deficiency.
Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5
Cécile Boulanger, et al
https://doi.org/10.1002/jimd.12509
Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
Eran Tallis, et al
https://doi.org/10.1002/jmd2.12304
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
Sarah Catharina Grünert, et al
https://doi.org/10.1002/jmd2.12295
Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5
Cécile Boulanger, et al
https://doi.org/10.1002/jimd.12509
Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
Eran Tallis, et al
https://doi.org/10.1002/jmd2.12304
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
Sarah Catharina Grünert, et al
https://doi.org/10.1002/jmd2.12295
More episodes of the podcast JIMD Podcasts
Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants
30/12/2025
Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff
23/12/2025
Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders
25/11/2025
IMD Research Round-Up: Mitochondrial disease
11/11/2025
In God we trust